Načítá se...

Review of Venetoclax in CLL, AML and Multiple Myeloma

Venetoclax is a highly selective and effective B-cell lymphoma-2 (BCL-2) inhibitor, which is able to reinstate the apoptotic potential of cancer cells. With its full repertoire yet to be explored, it has changed the therapeutic landscape in haematological malignancies, and most particularly chronic...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:J Pers Med
Hlavní autoři: Lasica, Masa, Anderson, Mary Ann
Médium: Artigo
Jazyk:Inglês
Vydáno: MDPI 2021
Témata:
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC8225137/
https://ncbi.nlm.nih.gov/pubmed/34073976
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/jpm11060463
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!